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Prenatal genetic counseling patients have the ability to choose from a myriad 
of screening and diagnostic testing options, each with intricacies and caveats 
regarding accuracy and timing. Decisions regarding such testing can be difficult and 
are often made on the same day that testing is performed. Therefore, it is 
reasonable to consider that the support people brought to an appointment may have 
a role in the decision-making process. We aimed to better define this potential role 
by examining the incoming knowledge and expectations of support people who 
attended prenatal genetic counseling appointments. 
 Support people were asked to complete a survey at one of seven Houston 
area prenatal clinics. The survey included questions regarding demographics, 
relationship to patient, incoming knowledge of the appointment, expectations of 
decision-making and perceived levels of influence over the decisions that would be 
made during the counseling session. 
 The majority (79.4%) of the 252 participants were spouses/partners. Overall, 
there was poor knowledge of the referral indications with only 33.5% of participants 
correctly identifying the patient’s indication. Participants had even poorer knowledge 
of testing options that would be offered during the session, as only 17.7% were able 
v 
 
to correctly identify testing options that would be discussed during the genetic 
counseling session. Of participants, just 3.6% said that they did not want to be 
included in discussions about screening/testing options. Only a few participants 
thought that they had less influence over decisions related to the pregnancy than 
over non-pregnancy decisions. Participants who reported feeling like they had a 
higher level of influence were likely to attend more of the pregnancy-related 
appointments with the patient.  
Findings from this study have provided insight into the perspective of support 
persons and have identified gaps in knowledge that may exist between the patients 
and the people they choose to bring with them into the genetic counseling session. 
In addition, this study is a starting point to assess how much the support people 
think that they impact the decision-making process of prenatal genetic counseling 
patients versus how much the prenatal patients value the input of the support 
people. 
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Introduction 
At a time when the field of genetics is constantly growing and changing, 
prenatal genetic counseling patients have the ability to choose from a myriad of 
screening and diagnostic testing options which include, but are not limited to, fetal 
comprehensive ultrasound (US), first trimester screening (FTS), chorionic villus 
sampling (CVS), genetic amniocentesis, and noninvasive prenatal testing (NIPT). 
There are intricacies and caveats regarding accuracy and timing of each available 
testing option.  
With the many screening and diagnostic testing options available to women 
during pregnancy, decision-making in a prenatal genetic counseling session can be 
difficult. Prenatal testing provides prospective parents with information during the 
pregnancy that will allow them to make informed decisions about moving forward 
(Lawson & Pierson, 2007). Other factors influence the counseling session and 
contribute to the complexity of making a decision regarding testing options and 
include the amount, quality, and type of information provided about each option 
(Jaques, Bell, Watson, & Halliday, 2004; Santalahti, Hemminikei, Latikka, & 
Ryynanen 1998). Due to the time sensitive nature of prenatal testing in general, 
women contemplating some and/or all of these options often make a decision 
regarding testing on the same day that the testing is performed. Therefore, it is 
reasonable to consider that the support people brought to the appointments may 
have a role in the decision-making process.  
Earlier studies have attempted to identify sources of support for women 
making prenatal testing decisions. Among the largest influences are 
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spouses/partners, parents, siblings, friends, and medical care providers. Most of the 
studies that evaluate support sources focus on the roles of healthcare providers and 
spouses/partners. These studies emphasize how support people hinder the 
autonomy of the women actually making the decisions (Lawson & Pierson, 2007). 
Lawson and Pierson looked at this topic from a different perspective and concluded 
that, for many women, the need to feel socially supported by people close to them 
predominates over their need for autonomy (2007). 
A study by Wohlgemuth and Lawson (2010) revealed that women identify 
husbands and physicians as the individuals from whom they desire the most 
support. Moreover, women who have social support in making their prenatal testing 
decisions reported feeling better prepared to make decisions about testing and were 
ultimately more confident in the decisions that they made. These findings highlight 
the importance of support people and the need for additional studies on this topic. 
In a genetic counseling session, support people are often included in the 
discussion about the prenatal testing options and are encouraged to share their 
feelings about the decisions being made. Support people, like prenatal patients, 
come from diverse backgrounds and walks of life and therefore come into the 
genetic counseling session with varying ideas and opinions about what will happen. 
As far as we know, a study has not been conducted to assess the incoming 
knowledge of the support people concerning what a genetic counseling session 
entails. The expectations of how the support person(s) should be included in the 
decision-making process are also currently undefined.  
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Since many prenatal patients bring support people with them to their 
appointments, presumably to help them make decisions about prenatal testing, it is 
essential to assess what this experience is like from the support person’s 
perspective. If we are able to establish a baseline of what most support people 
expect from or may wish to contribute to the session, genetic counselors may be 
able to provide targeted counseling that is more inclusive of support people brought 
to the appointments. 
 The objective of this study was to determine how much the support people 
know about the genetic counseling appointment prior to the session and to reveal 
how much they expect to be involved in the decision-making process. Findings from 
this study will provide insight into the perspective of the support person(s) and will 
hopefully help clinicians understand their expectations. Additionally, this pilot study 
is a starting point to assess how much the support people think that they impact 
decision-making of prenatal genetic counseling patients versus how much the 
prenatal patients value the input of these individuals. 
 
Materials and Methods 
The study population consisted of individuals over the age of 18 who spoke 
either English or Spanish and who came to a prenatal genetic counseling 
appointment with a patient at any of the seven University of Texas Health Maternal-
Fetal Medicine clinics in Houston (University of Texas Professional Building, St. 
Joseph Medical Center, Memorial Hermann Southeast, Memorial Hermann 
Southwest, Memorial Hermann Memorial City, Memorial Hermann Sugar Land, and 
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Memorial Hermann Katy). Human subjects approval was obtained through both the 
University of Texas Health Science Center at Houston and the Memorial Hermann 
Hospital System’s Institutional Review Boards (Approval # HSC-MS-12-0388). 
As genetic counseling patients checked in for their appointments, they were 
asked 1) if they brought a support person(s) over the age of 18; 2) if they were okay 
with their support person(s) being asked to take part in a survey; and 3) if that 
person(s) was willing to complete a survey prior to the genetic counseling session. 
The support person(s) was then given a letter of invitation (Appendix A) and was 
asked to complete a one page survey (Appendix B) which included demographics, 
their relationship to the patient, their incoming knowledge of the genetic counseling 
appointment, and how involved they expected to be in the decision-making process 
during the session. Each survey also contained a box for the genetic counselor to 
indicate the patient’s age and indication as well as testing offered to and accepted 
by the patient.  
Surveys were distributed at the seven UT clinics starting on various dates in 
August and September of 2012 and ending at all sites on January 31, 2013 (see 
Appendix C for specific dates).  A response rate was estimated for this study by 
collecting information from an existing database used by the UT prenatal 
counselors. This database includes information about whether or not the patient 
brought a support person(s) with them into the counseling room in the form of check 
boxes where the genetic counselor can select one or more relationships out of the 
following options: spouse, parent, child, sibling, friend, child >18, child <18, other, 
and none.  
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All data obtained from the surveys was entered into a secure Microsoft 
Access database. Data analysis was performed using STATA version 10.0 
software. Frequencies and percentages of responses were calculated for each 
question. Responses were stratified by indication and testing options offered. Chi 
square analysis was used to determine whether or not participants’ knowledge of 
indications and testing options was statistically significant. Mantel-Haenszel odds 
ratios were calculated to determine if there was a significant difference between the 
knowledge of the support persons who identified themselves as spouses/partners of 
the patient and those who identified themselves as non-spouses/partners of the 
patient. Wilcoxon-Mann-Whitney tests were used to assess the differences in 
attendance at appointments and levels of influence specifically between 
spouses/partners and parents of patients. 
 
Results 
The total number of patients seen at the clinic sites where surveys were 
collected within the dates specified was 964. An estimated 687 (71.3%) patients 
brought at least one support person into the genetic counseling session. A total of 
252 surveys were completed yielding an estimated response rate of 36.7%. Of the 
687 patients who brought at least one support person, 73 (10.7%) were Spanish-
speaking and 614 (83.4%) were English-speaking. Although the vast majority of the 
surveys collected were in English (n = 225, 89.3%), with the remainder in Spanish 
(n = 27, 10.7%), estimated response rates were similar between the two languages 
(36.6% and 37.0% respectively). The average age of the patients whose support 
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person completed a survey was 32.0±7.1 years and ranged from 15 to 49. Average 
gestational age in weeks was 17.7±5.6 and ranged from 6 weeks to 35 weeks. The 
average age of the support people, henceforth referred to as participants, was 36.0 
±9.8 years and ranged from 18 to 67 years. One hundred and ninety three (76.6%) 
of the participants were males, 50 (19.8%) were females, and 9 (3.6%) did not 
provide information about gender.  
Most participants (79.4%) were spouses/partners of the patients. Patients 
who brought a parent were significantly more likely to be younger than patients who 
brought a spouse/partner (p < 0.001). Participants were most often Hispanic 
(35.7%), Caucasian (27.4%), African-American (14.7%), or Asian (12.3%). The level 
of education of participants varied but the majority indicated that their highest level 
of education was high school graduate with or without some college (39.7%). The 
majority of participants identified themselves as Protestant Christians (27.4%) or 
Roman Catholics (27.4%). See Table 1 for participant demographics.  
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Table 1. Demographic information of study participants  
 
Total n = 252 n % 
Race   
American Indian 2 0.8 
Asian 31 12.3 
African American/Black 37 14.7 
African 3 1.2 
Hispanic/Latino 90 35.7 
Hawaiian/Pacific Islander 1 0.4 
White/Caucasian 69 27.4 
Multiracial 13 5.2 
Other 4 1.6 
Not Answered 2 0.8 
Education    
Some High School 17 6.8 
High School Grad 50 19.8 
Some College 50 19.8 
Trade/Tech/Voc 10 4.0 
College Grad 45 17.9 
Some Postgrad 4 1.6 
Postgrad Degree 40 15.9 
Other 10 4.0 
Not Answered 26 10.3 
Religion   
Protestant Christian 69 27.4 
Catholic 69 27.4 
Jewish 0 0.0 
Muslim 8 3.2 
Hindu 3 1.2 
Buddhist 1 0.4 
Other 56 22.2 
Not Answered 46 18.3 
Relationship to Patient   
Spouse/Partner 200 79.4 
Parent 27 10.7 
Child 0 0.0 
Sibling 8 3.2 
Friend 4 1.6 
Other 12 4.8 
Not Answered 1 0.4 
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Participants who marked a particular indication for genetic counseling were 
usually correct about advanced maternal age (AMA) and were correct around half of 
the time when selecting a positive screening result or a family history of a specific 
condition. However, out of all patients that the genetic counselor identified as AMA 
(46.0%), only 23.3% of participants were able to identify this as the reason for the 
appointment. Positive screen patients (25.8%) and family history patients (10.7%) 
were identified correctly by their support person about half of the time (42.2% and 
63.0% respectively). These results were statistically significant with p values < 
0.001. Although we did not have a large enough sample size in each of the 
relationship categories to stratify these results by relationship to the patient, we did 
compare the spouse/partner group to all other groups combined. There was no 
significant difference in the knowledge about the reasons for the patient’s 
appointment between spouses/partners and non-spouses/partners.  
Similarly to knowledge about indication, participants had little knowledge 
about which screening and testing options would be offered during the genetic 
counseling appointment. When participants marked a specific screen or test that 
they expected would be discussed, they were more often correct than incorrect. 
However, out of all patients that were offered each screening or testing option, only 
a small percentage of participants were able to identify the screens and test that 
would be offered. These results were all statistically significant with p values < 
0.001. Again, there was no significant difference in the knowledge about testing 
options between spouses/partners and non-spouses/partners. Information regarding 
indications and testing options is summarized in Figure 1. 
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Figure 1. Knowledge of indications and screening/testing options. Blue circles 
represent the number of patients for each indication and testing option as identified 
by the genetic counselor. The red circles represent the number of participants who 
marked the indication or testing option. The intersection of the two circles 
represents the number of participants who correctly identified the indication or 
testing option. (A) Knowledge of indications. (B) Knowledge of screening/testing 
options. 
A. 
 
B. 
 
 
Finally, we wanted to describe the expectations of support people about 
involvement in decision-making and the levels of influence they believe they have 
over those decisions. Eighty-nine point seven percent of participants reported that 
they planned to go with the patient to both the genetic counseling session and the 
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ultrasound. Fifty-two point eight percent of participants said that the patient had 
made a decision about testing prior to the counseling appointment. Of those, 45.9% 
reported that they helped make that decision, 47.4% did not answer the second part 
of the question, and only 6.8% marked that they did not help the patient make a 
decision about testing prior to the genetic counseling appointment. Although about 
half of participants stated that a decision about testing had been made prior to the 
appointment, 66.3% reported that they expected to help the patient make some type 
of decision during the genetic counseling session. Only 3.6% of participants marked 
that they did not want to be included in discussions about screening and/or testing 
options for the pregnancy. 
Among the patients that were accompanied to their appointments by 
participants, 59 (23.4%) were offered first trimester screening and 19 (32.2%) 
accepted, 60 (23.8%) were offered a CVS procedure and 11 (18.3%) accepted, 202 
(80.2%) were offered an amniocentesis procedure and 16 (7.9%) accepted, and 
166 (65.9%) were offered NIPT and 81 (48.8%) accepted. When asked about their 
beliefs about testing for fetal abnormalities during pregnancy in general, the majority 
of participants said either that their beliefs depended on the situation or that they 
are strongly for this type of testing. We compared the acceptance rate of each test 
and the responses to feelings about testing in general. There was no significant 
difference in the feelings about testing in general between those who were offered 
FTS (p = 0.807), amniocentesis (p = 0.617), or NIPT (p = 0.210) and declined and 
those who were offered FTS, amniocentesis, or NIPT and accepted. However, 
those who accepted the option to undergo a CVS procedure were significantly more 
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likely to report being strongly for testing than those who declined this procedure (p = 
0.044). Feelings about testing in general were also stratified by other demographic 
information. There was no significant difference in feelings about testing among 
education levels (p = 0.701) or religious affiliations (p = 0.646). There was, however, 
a significant difference in feelings about testing among race/ethnicity groups (p = 
0.039). Although there were a variety of answers in each of the groups, none of the 
African-American participants marked that they were “strongly against” testing while 
10.7% of Asian, 5.9% of Hispanic, and 1.4% of Caucasian participants reported 
those feelings. In addition, 19.4% of African-American participants marked “I don’t 
know” as a response to this question and only 10.7% of Asian, 8.2% of Hispanic, 
and 5.8% of Caucasian participants marked that response. Despite these significant 
differences, the vast majority of participants across all race categories chose that 
they were either “strongly for” testing or that it “depends on the situation”.  
Participants tended to be present at more appointments with the patient 
relating to pregnancy than appointments not related to pregnancy. Participants also 
thought that they had either the same or more influence over the patient’s decisions 
about pregnancy than they had over decisions that were not related to pregnancy. 
Both spouses/partners and non-spouses/partners showed a trend of feeling that 
they had either the same level or more influence over decisions related to the 
pregnancy than those not related to the pregnancy. There was no significant 
difference in the level of influence reported by spouses as compared to participants 
in all other relationship categories (p = 0.068). 
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Figure 2 shows a comparison between the reported levels of influence over 
pregnancy-related decisions with the participant’s attendance at pregnancy-related 
doctor’s appointments. Those who think they have a higher level of influence over 
pregnancy-related decisions were likely to attend more appointments. Conversely, 
those who reported that they had little to no influence over the patient’s decisions 
about the pregnancy report going to fewer appointments. 
 
Figure 2. Attendance at pregnancy-related physician appointments compared to 
reported level of influence over pregnancy-related decisions 
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Discussion 
It is well-documented that decisions about prenatal testing are influenced by 
factors other than the decision-making skills of the patient alone (Lawson & Pierson 
2007; Pergament & Pergament, 2012; Wohlgemuth & Lawson, 2010). Although it is 
known that support people influence prenatal testing decisions, there can be great 
variation in the level of influence (Santalahti et al., 1998; Sjogren & Uddenberg, 
1998). Our data supports this premise and found that the support people attending 
prenatal genetic counseling sessions, whether spouses/partners or other 
relationship types, expect to be involved in the education, discussion, and decision-
making aspects of the genetic counseling session. 
As expected, most support persons were spouses/partners and attended 
both the genetic counseling and ultrasound portions of the appointment. Proportions 
of the types of support people brought to the counseling sessions in our data 
appeared to be similar to those proportions in the existing prenatal database. 
Although not specifically analyzed, the proportions of each indication represented in 
the study population anecdotally correspond well to the general indications for 
prenatal genetic counseling. 
Overall, participant knowledge of patient indications for the genetic 
counseling session was poor. Across all of the screening and testing options, only a 
small percentage of participants marked the options that were actually offered to the 
patient during the genetic counseling session. A previous study reported that 83.8% 
of patients correctly identified an indication for which they were referred (Czerwinski 
et al., 2010). In contrast, only 33.5% of the support persons in this study were able 
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to correctly identify the patient’s indication. Despite their understanding of why they 
were referred, many women are not fully informed of the possible reproductive 
choices and testing options available to them (Li, Karlberk & Norem, 2008; Marteau 
& Dormandy, 2001; McCoyd, 2013; Pergament & Pergament, 2012). If we 
extrapolate our findings that support persons are less informed about indications 
than the patients, we would expect that support persons would be less 
knowledgeable about genetic testing options for the pregnancy. In our study, only 
17.7% of support persons were able to correctly identify at least one testing option 
that would be offered to the patient. Genetic counselors can incorporate this 
information to be more cognizant of the gap in knowledge that may exist between 
the patient and the support person. It is critical to assess not only what the patient 
understands about the reasons for the appointment and screening/testing options, 
but to also consider the knowledge of the support person(s) during the session. The 
influence of an under- or misinformed support person may negatively impact the 
decision-making process for the patients. 
The majority of participants in this study did expect to be involved in 
discussions about screening and testing options for the pregnancy and anticipated 
helping the patient make a decision during the genetic counseling appointment. 
Though genetic counselors at present may not ask a support person how frequently 
he or she attends pregnancy-related appointments with the patient, our data 
suggests that asking this question could provide the counselor a general idea about 
how much influence the support person thinks they have over the patient’s 
decisions.  
15 
 
We were unable to survey the patients themselves with similar questions due 
to clinic flow and time limitations. Comparing the patient’s knowledge and the level 
of influence that they believe the support person has with the support person’s 
knowledge and perception of their level of influence is important. Previous studies 
conclude that women in a prenatal setting want their support person(s) to be 
involved in the decision-making process (Nuccio et al., 2010). Our data 
demonstrates that the support people attending prenatal genetic counseling 
appointments want to be involved in discussions about screening and testing 
options. Additionally, support people on the whole believe that they have a higher 
level of influence over the patient’s pregnancy-related decisions than decisions not 
related to pregnancy. However, as discussed previously, their incoming knowledge 
of what will be discussed during the session is poor. Genetic counselors should 
acknowledge that educating support people about indications and screening/testing 
options can be just as important as the patient’s own understanding and these 
individuals should be actively engaged in the genetic counseling sessions.  
 
Limitations 
The most significant limitation of our study was the disagreement between 
the indication that the participant chose and the indication selected by the genetic 
counselor. Similarly, the options for testing that the participant expected to be 
discussed did not match up exactly with testing options that the genetic counselor 
could select. This discrepancy partially occurred as a result of using patient-friendly 
language for participants in the descriptions of indications and testing options and 
16 
 
made data analysis difficult. Data analysis of participant’s knowledge about 
abnormal ultrasound was particularly affected by participants choosing the option 
for their appointment being “to have an ultrasound”. Patients referred for all 
indications generally have and ultrasound after the genetic counseling session with 
the exception of preconception cases. Therefore, even if the patient’s indication was 
not “abnormal ultrasound”, the participant would have been correct by choosing the 
response indicating that the patient would have an ultrasound at her appointment. 
Also of note, a large number of participants skipped a question asking if they 
had helped the patient make a decision about testing prior to the appointment. This 
was most likely a result of the location of the question on the page that made the 
answer options less obvious than they were for the rest of the questions on the 
survey. 
Finally, although we had a large number of participants who identified 
themselves as the spouse/partner of the patient, our sample sizes for all other 
relationship groups were too small for use in stratifying the data by each 
relationship. Larger sample size in a future study may be more helpful in 
determining if incoming knowledge about indications and testing options is different 
for each of the relationship categories. In addition, about half of participants stated 
that the patient had already made a decision about testing before attending the 
appointment. Future studies may want to explore more specifically what decisions 
were made before the genetic counseling appointment, especially given the 
percentage of support people who said that they helped make that decision and the 
limited knowledge they may have about the testing options prior to the appointment. 
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Although the above limitations exist, this study was able to describe the types 
of support people that prenatal genetic counseling patients bring with them into the 
counseling session and included responses from over 250 participants. We have 
identified a gap in incoming knowledge that may exist between the patient and 
support person(s), which is important for the genetic counselor to address during 
the session. Finally, the findings from this study can be used in future studies to 
compare the level of influence the patients report that their support people have 
over their decisions to the perceived levels of influence described here. 
 
Conclusion 
In conclusion, this study aimed to determine who prenatal patients bring with 
them as support persons to genetic counseling appointments, what those support 
persons knew about the reasons for the appointment, and what their expectations 
were regarding involvement in the decision-making process. The vast majority 
(79.4%) of support persons were spouses/partners of the patient. In general, 
support persons were not knowledgeable about the reasons the patient was being 
seen by a genetic counselor and knew even less about the screening and testing 
options that would be discussed. However, the study found that support persons do 
expect to be involved in discussions and decision-making about screening/testing 
options and that they tend to feel that they have more of an influence over the 
patient’s pregnancy-related decisions than those not related to her pregnancy. The 
lack of knowledge about indications and genetic screening/testing options coupled 
with the desire to be involved in and influence decisions made about testing options 
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reinforces the importance of ensuring that the support person(s) brought to a 
prenatal genetic counseling session is appropriately included in the discussion. 
Since the support person(s) could potentially negatively impact the patient’s 
decision-making process if they do not fully understand both the indication for 
genetic counseling and the testing options, their comprehension is essential for a 
truly informed decision.  
  
19 
 
Appendix A: Letter of invitation 
 
20 
 
Appendix B: Survey 
 
21 
 
 
  
22 
 
Appendix B: Survey Distribution Dates 
University of Texas Professional Building: August 22, 2012 – January 31, 2013 
St. Joseph Medical Center: August 28, 2012 – January 31, 2013 
Memorial Hermann Katy: August 29, 2013 – January 31, 2013 
Memorial Hermann Memorial City: August 29, 2012 – January 31, 2013 
Memorial Hermann Southwest: August 31, 2012 – January 31, 2013 
Memorial Hermann Sugar Land: August 31, 2012 – January 31, 2013 
Memorial Hermann Southeast: September 5, 2012 – January 31, 2013 
  
23 
 
References 
Czerwinski JL, Wicklund CA, Hoskovec JM, King TM, Kerrigan AJ, and 
Mastrobattista JM (2010). Maternal Serum Screening: Results Disclosure, 
Anxiety, and Risk Perception. American Journal of Perinatology, 27(4): 279-
284. 
Jaques AM, Bell RF, Watson L, and Halliday JL (2004). People who influence 
women’s decisions and preferred sources of information about prenatal 
testing for birth defects. Aust N Z Obstet Gynaecol, 44(3): 233-8. 
Lawson K and Pierson RA(2007). Maternal Decision Regarding Prenatal Diagnosis: 
Rational Choices or Sensible Decisions? J Obstet Gynaecol Can, 29(3): 240-
246. 
Li, D.-K., Karlberg, K., Wi, S. and Norem, C. (2008), Factors influencing women's 
acceptance of prenatal screening tests. Prenat. Diagn., 28: 1136–1143. 
doi: 10.1002/pd.2142 
Marteau TM, Dormandy E (2001). Facilitating informed choice in prenatal testing: 
how well are we doing? AM J Med Gen, 106: 185-190. 
McCoyd JL (2013). Preparation for prenatal decision-making: a baseline of 
knowledge and reflection in women participating in prenatal screening. J 
Psychosom Obstet Gynaecol, 34(1): 3-8. Doi: 
10.3109/0167482X.2012.757590. 
Nuccio R, Singletary C, Hashmi S, Mastrobattista J, Smith J, Noblin SJ, and 
Refuerzo J (2010). Influence of Anchoring on Miscarriage Risk Perception 
24 
 
Associated with Amniocentesis. Unpublished Master’s Thesis, University of 
Texas Health Science Center – Houston. 
Pergament E and Pergament D (2012). Reproductive decisions after fetal genetic 
counseling. Best Pract Res Clin Obstet Gynaecol; 5: 517-29. Doi: 
10.1016/j.bpobgyn.2012.04.001. 
Santalahti P, Hemminiki e, Latikka AM< Ryynanen M (1998). Women’s decision-
making in prenatal screening. Soc Sci Med, 46: 1067-1076. 
Sjögren, B. and Uddenberg, N. (1988), Decision making during the prenatal 
diagnostic procedure. A questionnaire and interview study of 211 women 
participating in prenatal diagnosis. Prenat. Diagn., 8: 263–273. 
doi: 10.1002/pd.1970080404 
Wohlgemuth N and Lawson KL (2010). Prenatal testing: women’s autonomy, 
motivation and decisional well-being. Society for Reproductive and Infant 
Psychology Conference, 200; Amsterdam, NL. 
 
 
  
25 
 
Michelle Annette McDougle was born in Dalton, Georgia on August 20, 1987, the 
daughter of Paula Darlene McDougle and Michael Anthony McDougle. After 
completing her work in the International Baccalaureate program at Northwest 
Whitfield County High School, Tunnel Hill, GA in 2005, she entered Brenau 
University Women’s College in Gainesville, GA. She received the degree of 
Bachelor of Science with a major in Biology from Brenau in May, 2009. In August of 
2011 she entered the University of Texas Health Science Center at Houston 
Graduate School of Biomedical Sciences. 
 
Permanent address: 
494 Mount View Drive 
Tunnel Hill, GA 30755 
